您的位置：首页 > 产品中心 > 307002-71-7， CL-82198
CL-82198
| 产品编号： | 3426524 |
| 规格： | ≥98% (HPLC), powder |
| CAS NO： | 307002-71-7 |
| 包装规格： | 5 MG，25 MG |
| 产品类别： | 进口试剂 |
| 品牌： | Sigma-Aldrich |
| 优惠价： | 立即咨询 |
产品价格查看更多规格...
| 产品编号 | 包装单位 | 单价(元) | 国内现货 | 国外库存 | 询价单 |
| 3426524 | 5 MG | 932 | |||
| 3426524 | 25 MG | 3310 |
产品别名
307002-71-7
CL-82198
N-[4-(4-Morpholinyl)butyl]-2-benzofurancarboxamide
结构式
基本信息
| Empirical Formula【经验(实验)分子式】 | C17H22N2O3 |
| Molecular weight | 302.37 |
| MDL number | MFCD12828877 |
| PubChem Substance ID【PubChem化学物质编号】 | 329775209 |
| NACRES | NA.77 |
| Biochem/physiol Actions【生化/生理作用】 | CL-82198 is a selective inhibitor of MMP-13 that displays no activity at MMP-1, MMP-9 or TACE. It is also a selective S1′ pocket binder, binding within the entire S1′ pocket of MMP-13, docking with the morpholine ring adjacent to the catalytic zinc atom without zinc chelation. |
| Features and Benefits【特点和优势】 | This compound was developed by Wyeth. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here. |
产品性质
| Quality Level【质量水平】 | 100 |
| Assay【测定】 | ≥98% (HPLC) |
| form【形式】 | powder |
| color【颜色】 | white to off-white |
| solubility【溶解性】 | DMSO: >10 mg/mL |
| originator【创始人】 | Wyeth |
| storage temp.【储存温度】 | 2-8℃ |
| SMILES string | O=C(NCCCCN1CCOCC1)c2cc3ccccc3o2 |
| InChI | 1S/C17H22N2O3/c20-17(16-13-14-5-1-2-6-15(14)22-16)18-7-3-4-8-19-9-11-21-12-10-19/h1-2,5-6,13H,3-4,7-12H2,(H,18,20) |
| InChI key | KUJQEQAVMNFFAO-UHFFFAOYSA-N |
| packaging【包装】 | 5, 25 mg in glass bottle |
安全信息
| Pictograms【象形图】 | GHS07 |
| Signal word【警示用语：】 | Warning |
| Hazard Statements | H302 |
| Hazard Classifications【危险分类】 | Acute Tox. 4 Oral |
| Storage Class Code【储存分类代码】 | 11 - Combustible Solids |
| WGK | WGK 3 |
